{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:19:41Z","timestamp":1760955581040,"version":"3.40.5"},"reference-count":30,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.jvir.2015.07.019","type":"journal-article","created":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T21:21:23Z","timestamp":1440796883000},"page":"1630-1638","source":"Crossref","is-referenced-by-count":8,"title":["Yttrium-90 Glass-Based Microsphere Radioembolization in the Treatment of Hepatocellular Carcinoma Secondary to the Hepatitis B Virus: Safety, Efficacy, and Survival"],"prefix":"10.1016","volume":"26","author":[{"given":"Derek M.","family":"Biederman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph J.","family":"Titano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa S.","family":"Pierobon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myron","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo E.","family":"Facciuto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganesh","family":"Gunasekaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sander","family":"Florman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron M.","family":"Fischman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul S.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora E.","family":"Tabori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis S.","family":"Nowakowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8050-2366","authenticated-orcid":false,"given":"Edward","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2015.07.019_bib1","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1053\/j.gastro.2004.09.011","article-title":"Primary liver cancer: worldwide incidence and trends","volume":"127","author":"Bosch","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jvir.2015.07.019_bib2","unstructured":"GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. World Health Organization http:\/\/globocan.iarc.fr\/Pages\/fact_sheets_cancer.aspx. Accessed February 1, 2014."},{"key":"10.1016\/j.jvir.2015.07.019_bib3","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis","volume":"132","author":"El\u2013Serag","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jvir.2015.07.019_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1572-0241.2006.00364.x","article-title":"Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma","volume":"101","author":"Cantarini","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jvir.2015.07.019_bib5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0166-3542(01)00185-1","article-title":"Patterns of hepatocellular carcinoma development in hepatitis B virus and hepatitis C virus related cirrhosis","volume":"52","author":"Benvegn\u00f9","year":"2001","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jvir.2015.07.019_bib6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2009.09.006","article-title":"Radioembolization for hepatocellular carcinoma using yttrium-90 microspheres: a comprehensive report of long-term outcomes","volume":"138","author":"Salem","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jvir.2015.07.019_bib7","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/hep.24451","article-title":"Survival after yttrium\u201090 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation","volume":"54","author":"Sangro","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2015.07.019_bib8","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/hep.23944","article-title":"Radioembolization with yttrium\u201090 glass microspheres in hepatocellular carcinoma: european experience on safety and long\u2010term survival","volume":"52","author":"Hilgard","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2015.07.019_bib9","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/hep.26014","article-title":"Yttrium\u201090 radioembolization for intermediate\u2010advanced hepatocellular carcinoma: a phase 2 study","volume":"57","author":"Mazzaferro","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2015.07.019_bib10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s12072-014-9533-9","article-title":"Survival and pattern of tumor progression with yttrium-90 microsphere radioembolization in predominantly hepatitis B Asian patients with hepatocellular carcinoma","volume":"8","author":"Khor","year":"2014","journal-title":"Hepatol International"},{"key":"10.1016\/j.jvir.2015.07.019_bib11","first-page":"207","article-title":"Yttrium 90 microspheres for the treatment of hepatocellular carcinoma. Recent results in cancer research Fortschritte der Krebsforschung Progres dans les recherches sur le","volume":"190","author":"Memon","year":"2013","journal-title":"cancer."},{"key":"10.1016\/j.jvir.2015.07.019_bib12","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"Management of hepatocellular carcinoma","volume":"42","author":"Bruix","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2015.07.019_bib13","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"issue":"S2","key":"10.1016\/j.jvir.2015.07.019_bib14","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1002\/lt.20034","article-title":"The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma","volume":"10","author":"Llovet","year":"2004","journal-title":"Liver transpl"},{"key":"10.1016\/j.jvir.2015.07.019_bib15","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/01.RVI.0000233785.75257.9A","article-title":"Radioembolization with yttrium-90 microspheres: a state-of-the-Art brachytherapy treatment for primary and secondary liver malignancies: part 1: technical and methodologic considerations","volume":"17","author":"Salem","year":"2006","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2015.07.019_bib16","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00270-007-9064-z","article-title":"Radioembolization with 90Y microspheres: angiographic and technical considerations","volume":"30","author":"Lewandowski","year":"2007","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2015.07.019_bib17","first-page":"37S","article-title":"MIRD pamphlet no. 16: techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates","volume":"40","author":"Siegel","year":"1999","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jvir.2015.07.019_bib18","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/hep.27057","article-title":"Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology-pathology correlation and survival of radiation segmentectomy","volume":"60","author":"Vouche","year":"2014","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.jvir.2015.07.019_bib19","unstructured":"NIH. Common Terminology Criteria for Adverse Events (CTCAE) Version 4. 2009. p. 80."},{"key":"10.1016\/j.jvir.2015.07.019_bib20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jvir.2015.07.019_bib21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.jvir.2015.07.019_bib22","unstructured":"Centers for Disease Control and Prevention. National Death Index 2014. Available from: http:\/\/www.cdc.gov\/nchs\/ndi.htm. Accessed September 1, 2014"},{"key":"10.1016\/j.jvir.2015.07.019_bib23","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvir.2015.07.019_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jvir.2015.07.019_bib25","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jhep.2013.05.025","article-title":"Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma","volume":"59","author":"Golfieri","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jvir.2015.07.019_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2013.04.028","article-title":"Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization","volume":"11","author":"Salem","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jvir.2015.07.019_bib27","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1053\/j.gastro.2010.10.049","article-title":"Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma","volume":"140","author":"Salem","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jvir.2015.07.019_bib28","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jhep.2011.07.012","article-title":"Radioembolization for hepatocellular carcinoma","volume":"56","author":"Sangro","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jvir.2015.07.019_bib29","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/SLA.0000000000000917","article-title":"Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single north american center","volume":"260","author":"Franssen","year":"2014","journal-title":"Ann Surg"},{"key":"10.1016\/j.jvir.2015.07.019_bib30","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/hep.22747","article-title":"Radiologic\u2013pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium\u201090 microspheres","volume":"49","author":"Riaz","year":"2009","journal-title":"Hepatology"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044315006971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044315006971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T19:20:11Z","timestamp":1537384811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044315006971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S1051044315006971"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2015.07.019","relation":{},"ISSN":["1051-0443"],"issn-type":[{"type":"print","value":"1051-0443"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}